Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-10-01

Clinical Trial Update: Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase clinical trial update evaluating near-infrared light neuroprotection for glaucomatous optic neuropathy. The study is EARLY Phase 1 with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidad de Valparaiso | Conditions: Open Angle Glaucoma | EARLY_Phase 1 | Status: UNKNOWN